- Report
- March 2025
- 200 Pages
Global
From €2175EUR$2,490USD£1,889GBP
- Report
- April 2025
- 141 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- March 2025
- 147 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- August 2025
- 190 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 189 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- January 2025
- 200 Pages
Global
From €2175EUR$2,490USD£1,889GBP
- Report
- January 2025
- 256 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- April 2025
- 209 Pages
Global
From €2183EUR$2,500USD£1,897GBP
- Report
- October 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- July 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- October 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- October 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 182 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- April 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- January 2025
- 183 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- September 2025
- 177 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 210 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 294 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 170 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 697 Pages
Global
From €5109EUR$5,850USD£4,438GBP

The Respiratory Disorder market within the context of Pulmonary Medicine is a highly specialized field of medicine that focuses on the diagnosis and treatment of diseases and disorders of the lungs and airways. This includes conditions such as asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, pulmonary hypertension, and sleep-disordered breathing. Pulmonologists are the primary healthcare providers for these conditions, and they often work in collaboration with other specialists such as allergists, cardiologists, and thoracic surgeons. Treatment options for respiratory disorders include medications, lifestyle modifications, and in some cases, surgery.
Companies in the Respiratory Disorder market include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more